MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 2.1% of their position (3K shares) of NATERA, INC. on the open market
Open‑market sale worth $655.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 6/4/2026ACC: 0002010019-26-000015
Officer· PRESIDENT, CLINICALDIAGNOSTICS
Since Feb 2026
-3K
Net shares
Net seller
$655.3K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
3K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−1.80K
Price / share
$217.52
Trade value
$391.97K
% of position
1.3%
6/1/2026
140.64K→138.84K
Common Stock
Direct
Shares
−413.00
Price / share
$218.84
Trade value
$90.38K
% of position
0.3%
6/1/2026
138.84K→138.43K
Common Stock
Direct
Shares
−213.00
Price / share
$219.34
Trade value
$46.72K
% of position
0.2%
6/1/2026
138.43K→138.22K
Common Stock
Direct
Shares
−572.00
Price / share
$220.67
Trade value
$126.22K
% of position
0.4%
6/1/2026
138.22K→137.64K
Total
Net shares
−3K
Net value
-$655.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | S · Sale | −1.80K | $217.52 | $391.97K | 1.3% | 140.64K | 138.84K |
| Common Stock Direct | 6/1/2026 | S · Sale | −413.00 | $218.84 | $90.38K | 0.3% | 138.84K | 138.43K |
| Common Stock Direct | 6/1/2026 | S · Sale | −213.00 | $219.34 | $46.72K | 0.2% | 138.43K | 138.22K |
| Common Stock Direct | 6/1/2026 | S · Sale | −572.00 | $220.67 | $126.22K | 0.4% | 138.22K | 137.64K |
| Total | −3K | -$655.29K | ||||||
Derivative Transactions0
No derivative transactions reported